Premium
O1‐02–06: Twelve‐month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (ADNI)
Author(s) -
Reiman Eric M.,
Chen Kewei,
Ayutyat Napatkamon,
Lee Wendy,
Bandy Dan,
Reschke Cole,
Alexander Gene E.,
Weiner Michael W.,
Koeppe Robert A.,
Foster Norman L.,
Jagust William J.
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.225
Subject(s) - precuneus , posterior cingulate , medicine , neuroimaging , alzheimer's disease neuroimaging initiative , cognitive impairment , alzheimer's disease , randomized controlled trial , disease , cognitive decline , positron emission tomography , cardiology , cognition , dementia , psychiatry , radiology
Eric M. Reiman, Kewei Chen, Napatkamon Ayutyanont, Wendy Lee, Dan Bandy, Cole Reschke, Gene E. Alexander, Michael W. Weiner, Robert A. Koeppe, Norman L. Foster, William J. Jagust, Banner Alzheimer’s Institute, Arizona Alzheimer’s Consortium, Translational Genomics Research Institute, Phoenix, AZ, USA; University of Arizona, Tucson, AZ, USA; Banner Alzheimer’s Institute, Phoenix, AZ, USA; Arizona Alzheimer’s Consortium, Phoenix, AZ, USA; University of California, San Francisco, CA, USA; University of Michigan, Ann Arbor, MI, USA; University of Utah, Salt Lake City, UT, USA; University of California, Berkeley, CA, USA. Contact e-mail: Eric.Reiman@bannerhealth.com